Clinical Trial Update: RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating RAPID-WATER-FLOW, a radiolabeled perfusion technique to identify coronary artery disease; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)

Snippet

Sponsor: MedTrace Pharma A/S | Conditions: Coronary Artery Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING